This three-day course is designed exclusively for practitioners seeking to integrate ketamine administration safely and effectively into their clinical practices.
Day one focuses on foundational ketamine-assisted psychotherapy principles, including practice models, preparation and setting, breath work and holding space, safety considerations, and a guided multisensory immersion experience.
Day two builds on these essentials with applied clinical content, covering routes of administration, combining intranasal esketamine with IV ketamine, complex patient selection (including dual diagnosis, addictions, PTSD), navigation and integration, as well as coding, billing, payment, audit, enforcement, and properly insuring your ketamine practice.
Day three emphasizes advanced clinical decision-making and optimization of care, including choosing between treatments, neuroscience and pharmacology, a survey of ketamine research for mental health disorders, legal implications, hands-on optimization of IV infusion administration, and future directions for ketamine within the broader psychedelic landscape.
Attendees will receive a certificate of completion (must attend all programming to qualify), recognizing their achievement and participation in this training program. Registration is limited to 80 attendees. Register early and bring your medical staff!
Sponsored by the American Society of Ketamine Physicians, Psychotherapists and Practitioners (ASKP3), this is the only in-person training program that includes didactic sessions and hands-on learning.
A brief description of our registration selection options are as follows:
Please note: ASKP3 allows one (1) reduced price Additional Staff registration per registered Prescriber. If you would like to take advantage of an Additional Staff registration, please reach out to ASKP3 Headquarters for assistance at info@askp.org.
This program is designed exclusively for clinicians who are seeking to introduce ketamine to their practices to treat mood disorders and for pain management. Discounts are available for support staff, once the attending clinician has registered. This program is not for investors or non-clinicians.
Full payment is due at the time of registration. A refund less a $250 processing fee will be given for written cancellation requests received at ASKP3 Headquarters by August 3, 2026. No refunds will be given after August 3, 2026. Requests must be submitted to info@askp.org. In the event that the program is canceled or postponed, we will not be responsible for any travel costs or expenses, including cancellation/change penalties assessed by airlines, travel agencies or hotels.
Loading...
ASKP3 has secured discounted room rates at the Sheraton Denver Downtown Hotel, 1550 Court Place, Denver, Colorado. The discounted room rate is $299/night plus applicable taxes. Ask for the “ASKP” rate when booking your room.
Book your sleeping room accommodations by August 20 to take advantage of the discounted room rate. The discounted rate will be available until August 20 or until rooms sell out.
Sheraton Denver Downtown Hotel
1550 Court Pl
Denver, CO 80202
Click here for online booking.
Please note: ASKP3 does not partner with any third-party hotel vendors. Please book directly with the Sheraton Denver Downtown Hotel.
Montana Psychiatry & Brain Health Center
Jeff Becker, MD, Inc.
Klarisana
Ember Health
Houston Ketamine Therapeutics
Boise Ketamine Clinic
All attendees will receive a Certificate of Completion (must attend all sessions to qualify) at the evening session on Sunday, September 27. To receive CE credits, ASKP3 has partnered with PeerPoint Medical Education Institute for CMEs and with the American Association of Nurse Anesthesiology for MAC Ed Credits. Attendees will be provided instructions on reporting following completion of the program.
Participants must attend all three days of the program, in order to receive full credit.
The information provided at this CE activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
Statements by industry representatives during the program may not reflect the views and opinions of the ASKP3, its Board of Directors, faculty, or staff.